CHAM
IBB icon

Clear Harbor Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Clear Harbor Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$743K Buy
3,906
+1
+0% +$172 0.05% 262
2026
Q1 		$659K Hold
3,905
– – 0.05% 277
2025
Q4 		$659K Buy
3,905
+350
+10% +$56.8K 0.04% 263
2025
Q3 		$513K Hold
3,555
– – 0.04% 283
2025
Q2 		$450K Buy
3,555
+30
+0.9% +$3.68K 0.03% 285
2025
Q1 		$451K Buy
3,525
+380
+12% +$51.5K 0.04% 278
2024
Q4 		$416K Buy
3,145
+40
+1% +$5.62K 0.03% 263
2024
Q3 		$452K Hold
3,105
– – 0.04% 244
2024
Q2 		$426K Sell
3,105
-717
-19% -$95.7K 0.04% 244
2024
Q1 		$524K Buy
3,822
+129
+3% +$17.6K 0.05% 218
2023
Q4 		$502K Sell
3,693
-996
-21% -$122K 0.05% 216
2023
Q3 		$573K Sell
4,689
-139
-3% -$17.7K 0.06% 192
2023
Q2 		$613K Sell
4,828
-341
-7% -$44.3K 0.06% 190
2023
Q1 		$668K Buy
5,169
+390
+8% +$51.1K 0.07% 198
2022
Q4 		$627K Hold
4,779
– – 0.08% 184
2022
Q3 		$559K Buy
4,779
+725
+18% +$90K 0.08% 177
2022
Q2 		$477K Buy
4,054
+293
+8% +$34.8K 0.06% 218
2022
Q1 		$490K Buy
3,761
+1,963
+109% +$256K 0.06% 225
2021
Q4 		$274K Buy
+1,798
New +$278K 0.03% 315
2020
Q4 		– Sell
-330
Closed -$44.7K – 494
2020
Q3 		$44.7K Buy
+330
New +$44.8K 0.01% 402
2020
Q1 		– Sell
-345
Closed -$41.6K – 451
2019
Q4 		$41.6K Buy
+345
New +$38.5K 0.01% 428

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Clear Harbor Asset Management's IBB Position: Q2 2026 in Review

Clear Harbor Asset Management increased its iShares Biotechnology ETF (IBB) stake by 0.03% in Q2 2026, buying an estimated $172 and bringing the position to 3,906 shares worth $743K. The position accounts for 0.05% of the portfolio, ranked #262.

Clear Harbor Asset Management first reported a position in IBB in Q4 2019 and has held it in 21 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Clear Harbor Asset Management held 3,906 shares of iShares Biotechnology ETF worth $743K as of Q2 2026.
  • Clear Harbor Asset Management bought 1 iShares Biotechnology ETF share in Q2 2026, an estimated $172.
  • iShares Biotechnology ETF made up 0.05% of Clear Harbor Asset Management's portfolio in Q2 2026, its #262 holding.
  • Clear Harbor Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 21 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.